Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Neuro-Oncology Advances|April 26, 2024
Profiling the molecular and clinical landscape of glioblastoma utilizing the Oncology Research Information Exchange Network brain cancer databaseAlexandra N Demetriou, Frances Chow, David W Craig, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2018
Metastatic breast cancer patients' expectations and priorities for symptom improvementDanielle B Tometich, Catherine E Mosher, Adam T Hirsh, et al.Cancer|April 14, 2026
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancerKathy D Miller, Alexandra Thomas, Sandra Althouse, et al.The Journal of Molecular Diagnostics : JMD|April 22, 2022
Analytical Validation of a Computational Method for Pharmacogenetic Genotyping from Clinical Whole Exome SequencingReynold C Ly, Tyler Shugg, Ryan Ratcliff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100Bryan P Schneider, Molin Wang, Milan Radovich, et al.Molecular Cancer Therapeutics|August 28, 2020
Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid TumorsE Gabriela Chiorean, Susan M Perkins, R Matthew Strother, et al.Breast Cancer Research and Treatment|October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108Vered Stearns, Anne ONeill, Bryan P Schneider, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor-Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)Maura N Dickler, William T Barry, Constance T Cirrincione, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 25, 2024
Randomized Controlled Trial of Acceptance and Commitment Therapy for Fatigue Interference With Functioning in Metastatic Breast CancerCatherine E Mosher, Shieun Lee, Elizabeth L Addington, et al.Breast Cancer Research : BCR|August 7, 2019
Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancersBradley A Hancock, Yu-Hsiang Chen, Jeffrey P Solzak, et al.Pageof 12